PMID- 18202152 OWN - NLM STAT- MEDLINE DCOM- 20080721 LR - 20211020 IS - 0888-8809 (Print) IS - 1944-9917 (Electronic) IS - 0888-8809 (Linking) VI - 22 IP - 4 DP - 2008 Apr TI - Aldosterone regulates rapid trafficking of epithelial sodium channel subunits in renal cortical collecting duct cells via protein kinase D activation. PG - 881-92 LID - 10.1210/me.2007-0225 [doi] AB - Aldosterone elicits rapid physiological responses in target tissues such as the distal nephron through the stimulation of cell signaling cascades. We identified protein kinase D (PKD1) as an early signaling response to aldosterone treatment in the M1-cortical collecting duct (M1-CCD) cell line. PKD1 activation was blocked by the PKC inhibitor chelerythrine chloride and by rottlerin, a specific inhibitor of PKCdelta. The activation of PKCdelta and PKCepsilon coincided with PKD1 activation and while a complex was formed between PKD1 and PKCepsilon after aldosterone treatment, there was a concurrent reduction in PKD1 association with PKCdelta. A stable PKD1 knockdown M1-CCD-derrived clone was developed in which PKD1 expression was 90% suppressed by gene silencing with a PKD1-specific siRNA. The effect of aldosterone treatment on the subcellular distribution of enhanced cyan fluorescent protein (eCFP)-tagged epithelial sodium channel (ENaC) subunits in wild type (WT) and PKD1 suppressed cells was examined using confocal microscopy. In an untreated confluent monolayer of M1-CCD cells, alpha, beta, and gamma ENaC subunits were evenly distributed throughout the cytoplasm of WT and PKD1-suppressed cells. After 2 min treatment, aldosterone stimulated the localization of each of the ENaC subunits to discrete regions within the cytoplasm of WT cells. The translocation of eCFP-ENaC subunits in WT cells was inhibited by rottlerin and the mineralocorticoid receptor (MR) antagonist spironolactone. No subcellular translocation of eCFP-ENaC subunits was observed in PKD1-suppressed cells treated with aldosterone. These data demonstrate the involvement of a novel MR/PKCdelta /PKD1 signaling cascade in the earliest ENaC subunit intracellular trafficking events that follow aldosterone treatment. FAU - McEneaney, Victoria AU - McEneaney V AD - Department of Molecular Medicine, Royal College of Surgeons in Ireland Education and Research Centre, Smurfit Building, Beaumont Hospital, Dublin 9, Ireland. FAU - Harvey, Brian J AU - Harvey BJ FAU - Thomas, Warren AU - Thomas W LA - eng GR - 060809/z/00/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080117 PL - United States TA - Mol Endocrinol JT - Molecular endocrinology (Baltimore, Md.) JID - 8801431 RN - 0 (Acetophenones) RN - 0 (Benzophenanthridines) RN - 0 (Benzopyrans) RN - 0 (Epithelial Sodium Channels) RN - 27O7W4T232 (Spironolactone) RN - 4964P6T9RB (Aldosterone) RN - E29LP3ZMUH (rottlerin) RN - E3B045W6X0 (chelerythrine) RN - EC 2.7.10.- (protein kinase D) RN - EC 2.7.11.13 (Protein Kinase C) SB - IM MH - Acetophenones/pharmacology MH - Aldosterone/*pharmacology MH - Animals MH - Benzophenanthridines/pharmacology MH - Benzopyrans/pharmacology MH - Biological Transport/drug effects MH - Blotting, Western MH - Cell Line MH - Electrophoresis, Polyacrylamide Gel MH - Enzyme Activation/drug effects MH - Epithelial Sodium Channels/genetics/*metabolism MH - Immunoprecipitation MH - Kidney Cortex/cytology/drug effects/metabolism MH - Kidney Tubules, Collecting/cytology/*drug effects/metabolism MH - Mice MH - Microscopy, Confocal MH - Protein Kinase C/genetics/*metabolism MH - RNA Interference MH - Spironolactone/pharmacology PMC - PMC5419554 EDAT- 2008/01/19 09:00 MHDA- 2008/07/22 09:00 PMCR- 2009/04/01 CRDT- 2008/01/19 09:00 PHST- 2008/01/19 09:00 [pubmed] PHST- 2008/07/22 09:00 [medline] PHST- 2008/01/19 09:00 [entrez] PHST- 2009/04/01 00:00 [pmc-release] AID - me.2007-0225 [pii] AID - 10.1210/me.2007-0225 [doi] PST - ppublish SO - Mol Endocrinol. 2008 Apr;22(4):881-92. doi: 10.1210/me.2007-0225. Epub 2008 Jan 17.